Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.99-0.06 (-0.50%)
At close: 04:00PM EDT
11.99 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.05
Open11.80
Bid11.92 x 800
Ask11.97 x 800
Day's Range11.66 - 12.25
52 Week Range4.30 - 17.89
Volume257,974
Avg. Volume199,551
Market Cap617.827M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.56
Earnings DateMar 02, 2022 - Mar 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.00
  • GlobeNewswire

    Dyne Therapeutics Announces “Breakthrough Article” Publication of Duchenne Muscular Dystrophy Program Data in Nucleic Acids Research

    - FORCE™ Platform Achieves Enhanced Exon Skipping and Prolonged Dystrophin Restoration in Duchenne in vivo mdx Model - WALTHAM, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the publication of Duchenne muscular dystrophy (DMD) preclinical data in a “Breakthrough Article” in Nucleic Acids Resear

  • GlobeNewswire

    Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

    - Initiation of Patient Dosing in Multiple Ascending Dose Clinical Trials for DYNE-251 in DMD and DYNE-101 in DM1 On Track for Mid-2022 - WALTHAM, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the second quarter of 2022 and business highlights. “We are executing on our glob

  • Zacks

    Best Momentum Stocks to Buy for July 18th

    DINO, DYN, and DLNG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 18, 2022.

Advertisement
Advertisement